Mavik Oral Tablet 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mavik: Oral tablet (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2249.JPG
Mavik 1mg Tab
Knoll Pharmaceutical Co Sub BASF Corp
Pill Identification: KNOLL 1 
Drug Image file DrugItem_6951.JPG
Mavik 1mg Tab
AbbVie US LLC
Pill Identification: FT  |  LOGO
Drug Image file DrugItem_9179.JPG
Trandolapril 1mg Tab
Teva Pharmaceuticals USA
Pill Identification: 9 3  |  7325
Drug Image file DrugItem_10128.JPG
Trandolapril 1mg Tab
Lupin Pharmaceuticals, Inc.
Pill Identification: L U  |  H01
Drug Image file DrugItem_16867.JPG
Trandolapril 1mg Tab
AvKARE, Inc.
Pill Identification: 9 3  |  7325

What is this Medicine?

TRANDOLAPRIL (tran DOLE a pril) is an ACE inhibitor. This medicine is used to treat high blood pressure. It is also used to treat patients who have heart failure following a heart attack.

In-Depth Information
Select a Medication

Mavik 1mg Tablet

NDC: 000742278
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Mavik 1mg Tablet
Drug Image file DrugItem_6951.JPG
AbbVie US LLC
Pill Identification: FT  |  LOGO
Shape: round
Color: pink
Pregnancy & Lactation Information
First Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Second Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Third Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mavik

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5